Andreas Nägeli

Head of Business Development Genovis

Seminars

Wednesday 10th March 2027
GlyCLICK®: A Versatile Conjugation Platform for Improved ADCs
1:00 pm
  •  Introducing GlyCLICK® as an enzyme based platform for precise, site-specific antibody conjugation
  • Enabling highly homogeneous ADCs with defined DARs while preserving antibody function
  • Supporting controlled and scalable ADC generation across a broad range of antibody formats and payloads
Andreas Nageli - Genovis